*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

EXFORGE HCT® 5/160/25MG

Amlodipine (Amlodipine Besilate); Valsartan; Hydrochlorothiazide
5 mg; 160 mg; 25 mg
Tablet

ROA

Oral

Applicant Name

Novartis Nigeria Limited

NRN

A4-5824

Status

Active


ATC Code

C09DX01  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

4 X 7  

Product Description

163 AMS-PP-375657 EXFORGE HCT® 5/160/25MG AMLODIPINE + VALSARTAN + HYDROCHLOROTHIAZIDE Amlodipine besylate - 6.94mg Valsartan - 160mg Hydrochlorothiazide - 25mg Microcrystalline cellulose/ Cellulose microcrystalline - 142.06mg Crospovidone, type A - 54mg Colloidal silicon dioxide/ Silica, colloidal anhydrous – 3mg Magnesium stearate - 9mg A4-5824 Drugs Imported Products 4*7 POM 1 11/7/2023 NOVARTIS NIGERIA LIMITED, LANDMARK BUILDING 52/54 ISAAC JOHN STREET IKEJA-GRA LAGOS LAGOS 2.34707E+12 arit.onwusah@novartis.com Novartis Farma S.P.A, Novartis Farma S.P.A Torre Annunziata, Italy, Italy

Manufacturer Name

Novartis Farma S.p.A.

Manufacturer Country

ITALY  

Approval Date

2023-12-21  

Expiry Date

2028-12-20